Comparison of the success rate of treatment with Depomedrol injection and extracorporeal shock waves (ESWT) in patients with heel pain due to plantar fasciitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230807059066N1

Enrollment

Registered

2023-08-21

Start date

2023-08-22

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plantar fascitis. Other fibroblastic disorders

Interventions

Intervention 1: Intervention group: group a which is chosen by simple randomization and referred to physiotherapy for extracorporeal shock wave therapy that has a device put in contact with skin of he

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient has plantar fascitis patient agree to cooperate

Exclusion criteria

Exclusion criteria: radiculopathy AS and RA prior history of calcaneal fx calcaneal tumor advanced neuropathy

Design outcomes

Primary

Measure	Time frame
Score of disability due to plantar fasciitis by Oxford foot disability index. Timepoint: start of treatmet and 2 till 4 months after treatment. Method of measurement: oxford foot disability score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Hashemian

Islamic Azad University

al.hashemian@gmail.com+98 21 7763 3714

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026